Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2026 · 1 min read
In brief
In brief
This multi-institutional study evaluated indocyanine green fluorescence imaging as an alternative to technetium lymphoscintigraphy for sentinel lymph node mapping in 40 pediatric and adolescent patients with skin and soft tissue cancers. ICG demonstrated 79.5% sensitivity with a 96% positive predictive value across diverse tumor types including melanoma, squamous cell carcinoma, and sarcomas.
Written by the GCMD Library team from the article.
Statements in this article
Sentinel lymph node biopsy is a critical staging tool in skin and soft tissue cancers.
Technetium lymphoscintigraphy is the most common adjunct for sentinel lymph node biopsy.
Indocyanine green demonstrates a promising alternative to technetium lymphoscintigraphy in pediatric, adolescent, and young adult skin and soft tissue cancers.
Peritumoral indocyanine green was administered intraoperatively for sentinel lymph node biopsy.
Forty sentinel lymph node biopsy procedures yielded 84 specimens across melanoma, squamous cell carcinoma, non-rhabdomyosarcoma soft tissue sarcoma, rhabdomyosarcoma, Ewing sarcoma, and malignant peripheral nerve sheath tumor.
Of 81 lymph nodes identified, 75 were benign (89.3%) and six were malignant (7.1%).
76% of lymph nodes were indocyanine green-positive.
Indocyanine green had a sensitivity of 79.5%, a specificity of 33%, and a positive predictive value of 96% for sentinel lymph node detection.